Economics Principles in Vaccine Policy

The video discusses the application of economic principles like externalities and incentives to understand COVID-19 and vaccine policy. It uses the flu shot as an example of a positive externality, highlighting the social benefits of vaccinations. The video also explores how COVID-19 vaccine news impacts market prices and the under-incentivization of vaccine manufacturers. It addresses the challenges of innovation incentives and suggests policy solutions to enhance vaccine production. The video concludes with a summary of key economic principles and encourages further learning.

What is a positive externality in the context of flu vaccinations?

• A benefit received only by the person vaccinated

• A financial gain for vaccine manufacturers

• A cost incurred by the government

• A benefit to others when someone gets vaccinated

How do some firms internalize the positive externalities of vaccinations?

• By increasing employee salaries

• By offering free flu shots to workers

• By reducing work hours

• By providing free transportation

What happens to airline stocks when there is good news about a COVID-19 vaccine?

• They decrease significantly

• They remain unchanged

• They increase

• They become volatile

What is the economist's concern regarding vaccine manufacturers during the COVID-19 pandemic?

• They are profiting too much

• They are not profiting enough

• They are producing too many vaccines

• They are monopolizing the market

What percentage of the value of their innovations do innovators typically receive, according to William Nordhaus?

• 20 to 25%

• 2 to 2.5%

• 5 to 7%

• 10 to 15%

Why is a patent considered the wrong idea for COVID-19 vaccines?

• It lowers the price below the competitive price

• It raises the price above the competitive price

• It has no effect on pricing

• It is too difficult to obtain

What is one proposed solution to incentivize vaccine manufacturers without increasing their profits?

• Increasing taxes on vaccines

• Cutting their costs

• Reducing vaccine production

• Limiting market competition

Why is it important to build at-risk capacity for vaccine production?

• To delay the production process

• To increase competition among manufacturers

• To ensure availability once a vaccine is approved

• To reduce the cost of vaccines

What is the estimated cost of each month without a COVID-19 vaccine in the U.S.?

• No significant cost

• Dozens of lives and thousands of dollars

• Thousands of lives and billions of dollars

• Hundreds of lives and millions of dollars

What are the key principles of economics discussed in the video that can help improve policy in a pandemic?

• Consumer behavior, market structures, and elasticity

• Monetary policy, fiscal policy, and trade

• Supply and demand, market equilibrium, and inflation

• Externalities, incentives, and innovation policy